You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Johnson and Johnson
Merck
Moodys
Express Scripts

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

PROPULSID QUICKSOLV Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Propulsid Quicksolv patents expire, and what generic alternatives are available?

Propulsid Quicksolv is a drug marketed by Janssen Pharma and is included in one NDA.

The generic ingredient in PROPULSID QUICKSOLV is cisapride monohydrate. There are two drug master file entries for this compound. Additional details are available on the cisapride monohydrate profile page.

Summary for PROPULSID QUICKSOLV
Drug patent expirations by year for PROPULSID QUICKSOLV

US Patents and Regulatory Information for PROPULSID QUICKSOLV

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharma PROPULSID QUICKSOLV cisapride monohydrate TABLET, ORALLY DISINTEGRATING;ORAL 020767-001 Nov 7, 1997 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROPULSID QUICKSOLV

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharma PROPULSID QUICKSOLV cisapride monohydrate TABLET, ORALLY DISINTEGRATING;ORAL 020767-001 Nov 7, 1997   Get Started for $10   Get Started for $10
Janssen Pharma PROPULSID QUICKSOLV cisapride monohydrate TABLET, ORALLY DISINTEGRATING;ORAL 020767-001 Nov 7, 1997   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
McKinsey
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.